MedElevator Войти в исследования
← Поиск публикаций

DOI 10.18502/ijm.v18i1.20940

Медицинская библиотека · Iranian journal of microbiology · 2026

Clinical profile and outcome of COVID-19 associated mucormycosis in Shiraz, South Iran: a longitudinal study.

Kouhi Pariya, Mirhosseini Seyed Alireza, Ranjbar Maryam, Akbari Mohammadreza, Mehrabi Zeinab, Javaheri Rojan, Moosavi Mahsa, Alishahi Mohammad, Rasekh Kamran, Fathi Nazanin, Mansoori Yasaman

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND

OBJECTIVES

Numerous cases of mucormycosis appeared among COVID-19 patients, predominantly in Asian countries. This study aimed to investigate the clinical profile, in-hospital outcome, and one-year prognosis of COVID-19-associated mucormycosis (CAM).

MATERIALS AND

METHODS

All patients who developed CAM in Shiraz, South Iran, between July and October 2021 were included in this study. We collected data on presentations, comorbidities, risk factors, and outcomes.

RESULTS

Sixty-two patients with CAM were analyzed; the mean age was 59.3 years, and 58.1% were male. Diabetes mellitus was present in 80.6% (11.2% uncontrolled), hypertension in 54.8%, and chronic kidney disease in 11.3%. All patients had sinonasal involvement; ophthalmic, cutaneous, cerebral, gastrointestinal, pulmonary, and renal involvement occurred in 41.9%, 8.1%, 6.4%, 6.4%, 1.6%, and 1.6%, respectively. In-hospital and one-year mortality were 40.3% and 48.3%. Concurrent CAM and COVID-19, hypertension, older age, and radiologically severe COVID-19 lung involvement were associated with higher mortality. In multivariable analysis, age ≥60 years predicted in-hospital (OR: 5.47; 95% CI: 1.53-19.56) and one-year mortality (OR: 7.65; 95% CI: 1.90-30.84). Long-term mortality was also associated with ≥3 risk factors (OR: 4.12; 95% CI: 1.09-15.52) and lung severity index >30 (OR: 9.35; 95% CI: 1.01-86.63).

CONCLUSION

These findings emphasize the critical role of age in immune responses to opportunistic infections and highlight the impact of multiple comorbidities and severe lung damage on long-term prognosis in CAM.

Для цитирования: Kouhi Pariya, Mirhosseini Seyed Alireza, Ranjbar Maryam, Akbari Mohammadreza, Mehrabi Zeinab, Javaheri Rojan, Moosavi Mahsa, Alishahi Mohammad, Rasekh Kamran, Fathi Nazanin, Mansoori Yasaman. Clinical profile and outcome of COVID-19 associated mucormycosis in Shiraz, South Iran: a longitudinal study.. Iranian journal of microbiology. 2026. DOI: 10.18502/ijm.v18i1.20940.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.